Insights For Clinical Outsourcing For Biotechs

Planning, budgeting, and outsourcing clinical trials are key elements in the life cycle of a biotech company. There are so many considerations: study or program level scenario planning is instrumental to sharpening clinical execution plans; R&D pipeline cost estimates are required for fund raising, CFO reporting, or R&D partnership discussions. Each asset is precious, so selecting the right CRO/clinical service provider and performing operational and budget-level due diligence is mission critical. All these aspects of clinical operations are common to biopharmaceutical companies, but the biotechs have additional challenges; they are usually short staffed, moving at light speed, and lack the clinical outsourcing infrastructure that larger companies have built over many years of running trials. Learn:

1. How to overcome common challenges in clinical study planning and budgeting
2. Methodologies for effectively conducting CRO proposal due diligence and getting over analysis hurdle
3. Reviewing/changing your approach and your process

Hear insights from industry leader and respected subject matter expert- Bruno Gagnon, Senior Vice President, Development Operations at Eidos Therapeutics. Anca Copaescu, CEO of Strategikon will be talking with Bruno to discuss his experiences and how biotechs can embrace new perspectives in clinical outsourcing and will provide know how into challenges and solutions to help support your organization.